Mantabio
1 known investors
Find your way into Mantabio
Sign up to see every warm intro you have to Mantabio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mantabio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MantaBio builds an automated contamination and sterility testing platform for the drug supply chain, using a closed single-cartridge automated vPCR workflow (the MantaVision Automated vPCR Platform) for release and in-process microbial detection. It serves biopharma manufacturers, CDMOs, and clinical sites, deployable from the bioreactor floor to point-of-care manufacturing sites.
Founders & leadership
JR

Jack ReganCEO, CTO, and Co-FounderJack Regan has 19 years of experience in life science, tools, and diagnostic companies, with 8 years in executive roles. He founded LexaGene, which developed molecular diagnostics for veterinary clinics and grew to 58 employees before being acquired; he is now founder of MantaBio, which develops automated contamination and sterility testing for biopharmaceutical manufacturers.
CB

Carter BoisfontaineCo-founder · President
Investors · 1
Frequently asked questions
- What does Mantabio do?
- MantaBio builds an automated contamination and sterility testing platform for the drug supply chain, using a closed single-cartridge automated vPCR workflow (the MantaVision Automated vPCR Platform) for release and in-process microbial detection. It serves biopharma manufacturers, CDMOs, and clinical sites, deployable from the bioreactor floor to point-of-care manufacturing sites.
- Who founded Mantabio?
- Mantabio was founded by Jack Regan, Carter Boisfontaine.
- Who are Mantabio's investors?
- Mantabio's investors include Beacon Angels.
